ARCHIVES

New Drugs Improve Outlook For Bone Marrow Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 3 | March 31, 2006

Download PDF Visit The Full Archive

Related Articles

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

NIH wins A-76 competition for extramural support services.

September 26, 2003

DCPC Board approves 7 New RFAs, 2 Pas

October 21, 1994

Personal letters: mixed reviews of Donald Pinkel’s article on Childhood Lymphocytic Leukemia

May 6, 2021

NCI Restructures AIDS Effort; New Research Thrusts Recommended

October 5, 1984